Cargando…
Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study
Hepatitis C, caused by the hepatitis C virus (HCV), is a major public health issue in Russia. The aim of our study was to assess the seroprevalence of markers of HCV exposure and factors associated with HCV seropositivity among the general population aged 18–39 years in the city of Arkhangelsk, Nort...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711127/ https://www.ncbi.nlm.nih.gov/pubmed/31370746 http://dx.doi.org/10.1080/22423982.2019.1648970 |
_version_ | 1783446464529170432 |
---|---|
author | Balaeva, Tatiana Grjibovski, Andrej M. Samodova, Olga Sannikov, Anatoly Klouman, Elise |
author_facet | Balaeva, Tatiana Grjibovski, Andrej M. Samodova, Olga Sannikov, Anatoly Klouman, Elise |
author_sort | Balaeva, Tatiana |
collection | PubMed |
description | Hepatitis C, caused by the hepatitis C virus (HCV), is a major public health issue in Russia. The aim of our study was to assess the seroprevalence of markers of HCV exposure and factors associated with HCV seropositivity among the general population aged 18–39 years in the city of Arkhangelsk, Northwest Russia. A social research agency applied a quota sampling method to recruit study participants using cell phone numbers. All participants (n = 1243) completed a self-administered questionnaire and provided a blood sample. Sixty-five participants (5.2%, 95% confidence interval [CI] 4.9–5.5) tested positive for HCV IgM+G antibodies, and of these, 55 (84.6%) did not know that they were exposed to HCV. In multivariable logistic regression analysis, HCV seropositivity was significantly associated with older age, a history of injecting drug use, and having ever received a blood transfusion. To reach the goal of the World Health Organisation’s Global Health Sector Strategy on Viral Hepatitis, regional preventive programmes should include measures to reduce injecting drug use as well as scaling up harm-reduction and treatment programs for drug addicts. |
format | Online Article Text |
id | pubmed-6711127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-67111272019-09-05 Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study Balaeva, Tatiana Grjibovski, Andrej M. Samodova, Olga Sannikov, Anatoly Klouman, Elise Int J Circumpolar Health Original Research Article Hepatitis C, caused by the hepatitis C virus (HCV), is a major public health issue in Russia. The aim of our study was to assess the seroprevalence of markers of HCV exposure and factors associated with HCV seropositivity among the general population aged 18–39 years in the city of Arkhangelsk, Northwest Russia. A social research agency applied a quota sampling method to recruit study participants using cell phone numbers. All participants (n = 1243) completed a self-administered questionnaire and provided a blood sample. Sixty-five participants (5.2%, 95% confidence interval [CI] 4.9–5.5) tested positive for HCV IgM+G antibodies, and of these, 55 (84.6%) did not know that they were exposed to HCV. In multivariable logistic regression analysis, HCV seropositivity was significantly associated with older age, a history of injecting drug use, and having ever received a blood transfusion. To reach the goal of the World Health Organisation’s Global Health Sector Strategy on Viral Hepatitis, regional preventive programmes should include measures to reduce injecting drug use as well as scaling up harm-reduction and treatment programs for drug addicts. Taylor & Francis 2019-08-02 /pmc/articles/PMC6711127/ /pubmed/31370746 http://dx.doi.org/10.1080/22423982.2019.1648970 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Article Balaeva, Tatiana Grjibovski, Andrej M. Samodova, Olga Sannikov, Anatoly Klouman, Elise Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study |
title | Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study |
title_full | Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study |
title_fullStr | Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study |
title_full_unstemmed | Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study |
title_short | Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study |
title_sort | seroprevalence of markers of hepatitis c virus exposure and associated factors in adults aged 18-39 years in the arctic russian city of arkhangelsk: a cross-sectional study |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711127/ https://www.ncbi.nlm.nih.gov/pubmed/31370746 http://dx.doi.org/10.1080/22423982.2019.1648970 |
work_keys_str_mv | AT balaevatatiana seroprevalenceofmarkersofhepatitiscvirusexposureandassociatedfactorsinadultsaged1839yearsinthearcticrussiancityofarkhangelskacrosssectionalstudy AT grjibovskiandrejm seroprevalenceofmarkersofhepatitiscvirusexposureandassociatedfactorsinadultsaged1839yearsinthearcticrussiancityofarkhangelskacrosssectionalstudy AT samodovaolga seroprevalenceofmarkersofhepatitiscvirusexposureandassociatedfactorsinadultsaged1839yearsinthearcticrussiancityofarkhangelskacrosssectionalstudy AT sannikovanatoly seroprevalenceofmarkersofhepatitiscvirusexposureandassociatedfactorsinadultsaged1839yearsinthearcticrussiancityofarkhangelskacrosssectionalstudy AT kloumanelise seroprevalenceofmarkersofhepatitiscvirusexposureandassociatedfactorsinadultsaged1839yearsinthearcticrussiancityofarkhangelskacrosssectionalstudy |